<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04217239</url>
  </required_header>
  <id_info>
    <org_study_id>MIE ZYP2</org_study_id>
    <nct_id>NCT04217239</nct_id>
  </id_info>
  <brief_title>A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy</brief_title>
  <official_title>A Comparison of Short-term and Long- Term Outcomes Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Second Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Second Hospital of Shandong University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Surgery is still the main treatment for esophageal cancer, however, the complication and
      mortality rate of open esophagectomy is high. As a result, the thoracoscopic- laparoscopic
      minimally invasive esophagectomy (MIE) was developed. The MIE mainly comprised two surgical
      approaches:

      MIE McKeown approach (cervical anastomosis) and MIE Ivor-Lewis approach
      (intrathoracicanastomosis). The MIE with intrathoracic anastomosis (Ivor-Lewis) is
      increasingly used for the treatment of mid and lower esophageal cancers. Our study is trying
      to compare the safety, feasibility, and short-term and long- term outcomes between MIE
      Ivor-Lewis approach and MIE McKeown approach for the treatment of lower thoracic esophageal
      cancer and esophageal- gastric junction.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2028</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operating time</measure>
    <time_frame>1 day</time_frame>
    <description>Operating time in minutes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood loss</measure>
    <time_frame>1 day</time_frame>
    <description>Blood loss in milliliter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lymph nodes harvested</measure>
    <time_frame>1 day</time_frame>
    <description>Lymph nodes harvested in number</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pulmonary complication</measure>
    <time_frame>1 month</time_frame>
    <description>Pulmonary complication in rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anastomotic leakage</measure>
    <time_frame>within one month</time_frame>
    <description>Anastomotic leakage in rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Anastomotic stenosis</measure>
    <time_frame>within three months</time_frame>
    <description>Anastomotic stenosis in rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>recurrent laryngeal nerve injury</measure>
    <time_frame>within three months</time_frame>
    <description>recurrent laryngeal nerve injury in rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Chylothorax</measure>
    <time_frame>within one month</time_frame>
    <description>Chylothorax in rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Cardiac arrhythmia</measure>
    <time_frame>within one month</time_frame>
    <description>Cardiac arrhythmia in rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital stay</measure>
    <time_frame>within 60 days</time_frame>
    <description>Hospital stay in days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>mortality</measure>
    <time_frame>within 90 days</time_frame>
    <description>mortality in rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>progression-free survival</measure>
    <time_frame>within 5 years</time_frame>
    <description>progression-free survival in rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall survival</measure>
    <time_frame>within 5 years</time_frame>
    <description>overall survival in rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Esophageal Cancer</condition>
  <arm_group>
    <arm_group_label>Ivor-Lewis group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>minimally invasive esophagectomy (MIE) with intrathoracic anastomosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>McKeown group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>minimally invasive esophagectomy (MIE) with cervical anastomosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MIE Ivor- Lewis</intervention_name>
    <description>minimally invasive esophagectomy (MIE) with intrathoracic anastomosis</description>
    <arm_group_label>Ivor-Lewis group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MIE McKeown</intervention_name>
    <description>minimally invasive esophagectomy (MIE) with cervical anastomosis</description>
    <arm_group_label>McKeown group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        (I) Patients with clinically staged T1-3N0-2M0 tumors; good cardiopulmonary function;

        (II) Patients with lower thoracic esophageal tumors and esophageal- gastric junction tumor;

        (III) Patients without a previous history of cancer;

        (IV) Patients without a previous history of neck or chest surgery;

        Exclusion Criteria:

        (I) cardiopulmonary function not good enough for surgery;

        (II) Patients with hybrid MIE
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Yunpeng Zhao</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250033</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunpeng Zhao</last_name>
      <phone>+8618766188692</phone>
      <email>zyp_baggio@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 1, 2020</study_first_submitted>
  <study_first_submitted_qc>January 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2020</study_first_posted>
  <last_update_submitted>January 2, 2020</last_update_submitted>
  <last_update_submitted_qc>January 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thoracoscopic</keyword>
  <keyword>laparoscopic</keyword>
  <keyword>esophagectomy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

